CONTRAFECT Corp

YONKERS, NY How do I update this listing?

Contrafect Corp is based out of Yonkers. ContraFect Corporation operates as a biotechnology company. The Company develops protein, antibody therapeutic products for life-threatening and drug resistant infectious diseases.Whalewisdom has at least 107 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-06-25. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

contrafect corp
28 WELLS AVENUE
YONKERS NY    10701

Business Phone: 914-207-2300
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-06-25 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 20,000,000 20,000,000 0
2014-03-12 D BIOTECHNOLOGY Equity INDEFINITE 0 INDEFINITE
2013-09-04 D/A BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 15,000,000 11,963,650 3,036,350
2013-07-01 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 10,000,000 9,997,650 2,350
2011-09-15 D BIOTECHNOLOGY Equity 25,000,000 12,502,905 12,497,095
2010-08-23 D BIOTECHNOLOGY Equity 10,000,000 4,326,603 5,673,397
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CARY W. SUCOFF subscription required
    DIRECTOR
DAVID HUANG, M.D., PH.D subscription required
    EXECUTIVE OFFICER
DAVID N. LOW, JR. subscription required
    DIRECTOR
DAVID SCHEINBERG subscription required
    DIRECTOR
DAVID SCHEINBERG, M.D., PH.D. subscription required
    DIRECTOR
ISAAC BLECH subscription required
    DIRECTOR
ISSAC BLECH subscription required
    DIRECTOR
JOHN ABELES subscription required
    DIRECTOR
JULIA P. GREGORY subscription required
    EXECUTIVE OFFICER
LAWRENCE YUAN TIAN, PH.D. subscription required
    DIRECTOR
MICHAEL MESSINGER subscription required
    EXECUTIVE OFFICER
MICHAEL J. OTTO, PH.D. subscription required
    DIRECTOR
MICHAEL WITTEKIND, PH.D. subscription required
    EXECUTIVE OFFICER
NATALIE BOGDANOS subscription required
    EXECUTIVE OFFICER
ROBERT C. NOWINSKI subscription required
    EXECUTIVE OFFICER
ROBERT NOWINSKI, PH.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
ROGER POMERANTZ, PH.D. subscription required
    DIRECTOR
SHENGDA ZAN subscription required
    DIRECTOR
SIR RICHARD SYKES, FRS subscription required
    DIRECTOR
SOL BARER subscription required
    DIRECTOR
SOL BARER, PH.D. subscription required
    DIRECTOR
STEVEN C. GILMAN, PH.D. subscription required
    DIRECTOR

Elevate your investments